Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
2.4%
1w
2.7%
1m
3.8%
3m
38.8%
6m
67.7%
1y
22.1%
all
16.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 607 2.4%
426
647
Company Overview

Sales
886 Cr
Growth: -10.6%
Profit after Tax
235 Cr
Growth: -5.2%
Mid Cap
11,489 Cr
P/E: 44.8x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 886
Growth -10.6%
EBITDA 30.6%
P/S 13.0x
Dividend 0.2%
P/E 44.8x
Book Value ₹ 76
PEG Ratio -4.1x
ROE 17.4%
P/B 7.8x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)